Article Versions Notes

Cangelosi D, Morini M, Zanardi N, Sementa AR, Muselli M, Conte M, Garaventa A, Pfeffer U, Bosco MC, Varesio L, et al. Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. Cancers. 2020; 12(9):2343. https://doi.org/10.3390/cancers12092343

Cangelosi, Davide, Martina Morini, Nicolò Zanardi, Angela Rita Sementa, Marco Muselli, Massimo Conte, Alberto Garaventa, Ulrich Pfeffer, Maria Carla Bosco, Luigi Varesio, and et al. 2020. "Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming" Cancers 12, no. 9: 2343. https://doi.org/10.3390/cancers12092343

Cangelosi, D., Morini, M., Zanardi, N., Sementa, A. R., Muselli, M., Conte, M., Garaventa, A., Pfeffer, U., Bosco, M. C., Varesio, L., & Eva, A. (2020). Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. Cancers, 12(9), 2343. https://doi.org/10.3390/cancers12092343